Dipeptides with a short side chains as potential drug candidates

Pharmaceutical Regulatory Affairs: Open Access

ISSN: 2167-7689

Open Access

Dipeptides with a short side chains as potential drug candidates

15th Annual European Pharma Congress

May 07-09, 2018 | Frankfurt, Germany

Anna Szemik-Hojniak

University of Wroclaw, Poland

Keynote: Pharmaceut Reg Affairs

Abstract :

Quinoxaline and its derivatives are at the forefront of organic compounds with a wide range of biological activities (antibacterial, antiviral or anticancer properties). Recently, we synthesized dipeptides containing quinoxaline-derived amino acid side chains. They show a limited steric hindrance and may exist in numerous conformations. This property can be explored in pharmaceutical applications. In this talk, the results of experimental absorption and emission steady state and timeresolved spectroscopy along with theoretical (DFT) calculations on the synthesized dipeptides containing the 3-(quinoxalin6-yl)alanine residue will be presented. These are: N-(3-(2, 3-diphenylquinoxaline-6-ylo)alanylo) glycine dipeptide [Pe-DPhQ] and diphenylquinoxaline (DPhQ) pair, as well as N-(3-(2, 3(pirydine-2-ylo) quinoxaline-6-ylo)alanylo) glycine dipeptide (PeDPiQ) and dipyridyl-iso-quinoxaline (DPiQ) pair. The DFT calculations reveal that Pe-DPiQ dipeptide is the most stable and may exist in three ground state optimized isomers. In this isomer, the OH...N hydrogen bond is present and the excited state proton transfer can occur. At room temperature, in highly polar solvents, emission (403 nm) decays bi-exponentially (├Ć┬?1= 2.0 ns, ├Ć┬?2= 8.9 ns) while with lowering temperature, besides a weak fluorescence that is slightly redshifted (410 nm; 2.5 and 38.2 ns); also, the phosphorescence band at 495 nm (├Ć┬?1=1.0 ├?┬╝s and ├Ć┬?2=9.0 ├?┬╝s) is observed. On the other hand, at elevated temperatures, a new broad, structurless and strongly red shifted fluorescence band (563 nm) appears (the Stokes shift ~12000 cm-1) suggesting the strong excited state charge transfer (CT) interactions. It├ó┬?┬?s origins from the isomer where one of the two pyridine side rings are more or less coplanar with respect to the quinoxaline plane. One may conclude that recognizing of the electronic structure, the CT and proton transfer abilities in the short peptides are highly important for explaining the splitting and conformational dynamics in proteins. This in turn allows treating such systems as novel groups of potential drug candidates.

Biography :

Anna Szemik-Hojniak has completed her PhD in Radiochemistry from the University of Wroclaw and Post-doctoral Studies from Solvay Foundation (Belgium), KU Leuven (Belgium) and Centre of Nuclear Researches (Strasburg, France). She is an experienced Researcher and Academic Teacher and occupied with Organic Molecular Photophysics. She has published more than 50 papers in reputed scientific journals and has been serving as a Reviewer. In 2014 and 2015, she organized a Mini Symposium on “Photophysics of Electron and Proton Transfer” in the framework of ICCMSE2014 Conference in Athens (Greece) and during Pharma 2015 and Pharma 2016 she gave the Keynote Lectures on Drug Design. Presently, she serves as General Secretary and the Board Director of INWES-ERI Corporation, Operational Partner of UNESCO (headquarters-Ottawa, Canada).
Email:[email protected]

50+ Million Readerbase

Journal Highlights

Google Scholar citation report
Citations: 400

Pharmaceutical Regulatory Affairs: Open Access received 400 citations as per Google Scholar report

Pharmaceutical Regulatory Affairs: Open Access peer review process verified at publons

Indexed In

arrow_upward arrow_upward